AltinCSadeLGezmisE. Assessment of subclinical atherosclerosis by carotid intima–media thickness and epicardial adipose tissue thickness in prediabetes. Angiology. 2016;67(10):961–969.
2.
BergAHSchererPE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96(9):939–949.
3.
Van GaalLFMertensILDe BlockCE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875–880.
4.
KatsikiNAthyrosVGKaragiannisA. Hyperuricaemia and non-alcoholic fatty liver disease (NAFLD): a relationship with implications for vascular risk?Curr Vasc Pharmacol. 2011;9(6):698–705.
5.
GrundySMCleemanJIDanielsSR; American Heart Association/National Heart Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735–2752.
6.
IacobellisG. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nature Rev Endocrinol. 2015;11(6):363–371.
7.
YorgunHCanpolatUHazirolanT. Increased epicardial fat tissue is a marker of metabolic syndrome in adult patients. Int J Cardiol. 2013;165(2):308–313.
8.
CanpolatUAytemirKYorgunH. The impact of echocardiographic epicardial fat thickness on outcomes of cryoballoon-based atrial fibrillation ablation. Echocardiography. 2016;33(6):821–829.
9.
YorgunHCanpolatUHazirolanT. Epicardial adipose tissue thickness predicts descending thoracic aorta atherosclerosis shown by multidetector computed tomography. Int J Cardiovasc Imaging. 2012;28(4):911–919.
10.
KatsikiNMikhailidisDPWierzbickiAS. Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol. 2013;28(4):458–463.
11.
ColakYKarabayCYTuncerI. Relation of epicardial adipose tissue and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2012;24(6):613–618.
12.
EgeMRGurayUGurayY. Serum gamma-glutamyltransferase levels correlate with epicardial adipose tissue thickness in patients with coronary artery disease. Angiology. 2013;64(1):21–25.
13.
GhouriNPreissDSattarN. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology. 2010;52(3):1156–1161.
14.
Fernandez-TrasancosAFandino-VaqueroRAgraRM. Impaired adipogenesis and insulin resistance in epicardial fat-mesenchymal cells from patients with cardiovascular disease. J Cell Physiol. 2014;229(11):1722–1730.
15.
DozioEVianelloEBrigantiS. Expression of the receptor for advanced glycation end products in epicardial fat: link with tissue thickness and local insulin resistance in coronary artery disease. J Diabetes Res. 2016;2016:2327341.
16.
Blachnio-ZabielskaAUBaranowskiMHirnleT. Increased bioactive lipids content in human subcutaneous and epicardial fat tissue correlates with insulin resistance. Lipids. 2012;47(12):1131–1141.
